Skip to content

Monocentric cohort study to evaluate the artificial urinary sphincter Victo and Victo+

Monocentric cohort study to evaluate the artificial urinary sphincter Victo and Victo+ - Vena

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00018990
Enrollment
80
Registered
2020-01-31
Start date
2020-01-30
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male stress urinary incontinence N39.3

Interventions

Group 1: Male patients, who received an artificial urinary sphincter Victo or Victo+ of the third generation will be retrospectively evaluated concerning functional outcome and complication rates. F

Sponsors

Promedon GmbH
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: male patients with a age > 18 years Male Patients who received a Victo or Victo+ of the third generation for the treatment of male urinary stress incontinence

Exclusion criteria

Exclusion criteria: missing signed informed consent

Design outcomes

Primary

MeasureTime frame
Urinary continence which is defined with the usage of 0 to 1 pad/day

Secondary

MeasureTime frame
Complication rates, Revision- and explantation free survival, time period of being continent, 24h pad test, validated questionare PGI-I, ICIQ-SF and I-QoL

Countries

Austria

Contacts

Public ContactGhazal Amelie

Klinik für Urologie Landesklinikum Korneuburg

ghazal.ameli@korneuburg.lknoe.at+43 2262 9004 5740

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026